File Download
Supplementary

Conference Paper: Blocking the PI3K/AKT pathway can impair metastasis of esophageal cancer

TitleBlocking the PI3K/AKT pathway can impair metastasis of esophageal cancer
Authors
Issue Date2014
PublisherWorld Cancer Congress.
Citation
The 2014 World Cancer Congress (WCC), Melbourne, Australia, 3-6 December 2014, abstract 942 How to Cite?
AbstractBACKGROUND: Esophageal cancer (EC) is an aggressive malignancy with increasing incidence and poor outcome (1). New therapeutic strategies are urgently required. The phosphatidylinositol 3-kinase (PI3K)/AKT signal pathway has been documented as a central hub for the malignant behaviors of cancer cells (2). However, the functional role and therapeutic effect of PI3K/AKT inhibitors in esophageal cancer metastasis is underappreciated. AIM: We aim to study the clinical significance of PI3K/AKT signaling pathway in EC metastasis and evaluate the therapeutic effect ...
DescriptionE-posters: 6.5 Scientific Study - Diagnosis/Treatment: no. 942
The Conference program's website is located at http://wcc-2014.p.asnevents.com.au/tracks/653
Persistent Identifierhttp://hdl.handle.net/10722/207780

 

DC FieldValueLanguage
dc.contributor.authorXu, W-
dc.contributor.authorLi, B-
dc.contributor.authorLi, YY-
dc.contributor.authorTsao, SW-
dc.contributor.authorCheung, ALM-
dc.date.accessioned2015-01-19T10:41:19Z-
dc.date.available2015-01-19T10:41:19Z-
dc.date.issued2014-
dc.identifier.citationThe 2014 World Cancer Congress (WCC), Melbourne, Australia, 3-6 December 2014, abstract 942-
dc.identifier.urihttp://hdl.handle.net/10722/207780-
dc.descriptionE-posters: 6.5 Scientific Study - Diagnosis/Treatment: no. 942-
dc.descriptionThe Conference program's website is located at http://wcc-2014.p.asnevents.com.au/tracks/653-
dc.description.abstractBACKGROUND: Esophageal cancer (EC) is an aggressive malignancy with increasing incidence and poor outcome (1). New therapeutic strategies are urgently required. The phosphatidylinositol 3-kinase (PI3K)/AKT signal pathway has been documented as a central hub for the malignant behaviors of cancer cells (2). However, the functional role and therapeutic effect of PI3K/AKT inhibitors in esophageal cancer metastasis is underappreciated. AIM: We aim to study the clinical significance of PI3K/AKT signaling pathway in EC metastasis and evaluate the therapeutic effect ...-
dc.languageeng-
dc.publisherWorld Cancer Congress.-
dc.relation.ispartofWorld Cancer Congress, WCC 2014-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleBlocking the PI3K/AKT pathway can impair metastasis of esophageal cancer-
dc.typeConference_Paper-
dc.identifier.emailLi, B: libinhku@hkucc.hku.hk-
dc.identifier.emailLi, YY: yyli@hku.hk-
dc.identifier.emailTsao, SW: gswtsao@hku.hk-
dc.identifier.emailCheung, ALM: lmcheung@hku.hk-
dc.identifier.authorityTsao, SW=rp00399-
dc.identifier.authorityCheung, ALM=rp00332-
dc.description.naturepostprint-
dc.identifier.hkuros242209-
dc.publisher.placeMelbourne, Australia-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats